cp wire

CP Wire Articles

GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment


GO Therapeutics, Inc. (GO) announced on 10/2/18 that it has entered into a license agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (Roche). Under the terms of the agreement... read more

Tue, 10/2/18 - 09:58 am
Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca for Metastatic Castration Resistant Prostate Cancer
  • Rubraca previously received Breakthrough designation for the monotherapy treatment of certain advanced ovarian cancer patients
  • Rubraca is indicated as monotherapy for the treatment... read more
Tue, 10/2/18 - 09:49 am
Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018


Rebiotix Inc., part of the Ferring Pharmaceuticals Group, announced on 10/1/18 that data new from their Microbiota Restoration Therapy™ (MRT) drug... read more

Mon, 10/1/18 - 11:29 pm
ADMA Biologics Resubmits BLA for Primary Immunodeficiency Disease Drug
  • ADMA received a CRL in July of 2016
  • The Company was able to resubmit RI-002’s BLA as a direct result of the recent improvement in compliance status for the Company’s Boca Raton, FL... read more
Mon, 10/1/18 - 10:00 am
Seattle Genetics' and Takeda's Adcetris Meets Primary and Secondary Endpoints in Ph III Trial for T-Cell Lymphoma
  • Results from the trial demonstrated that combination treatment with Adcetris plus CHP was superior to the control arm for progression free survival (PFS)
  • All other key secondary... read more
Mon, 10/1/18 - 09:28 am

Pages